Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

The Alchemist – Canary Wharf Reuters Plaza, E14 5AJ London

  1. Events
  2. Venues
  3. The Alchemist – Canary Wharf Reuters Plaza, E14 5AJ London
Events at this venue
Today

BioTrinity Investor Networking Drinks 2025

This is an exclusive evening of networking at the BioTrinity Investor Drinks. Held the night before OBN’s premier partnering and investment conference, this event offers [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2024 | Hlx Life Sciences

Site by theLEAP

Go to Top